If manufacturers cannot ensure safe, cost-effective delivery of treatments for rare diseases, access will remain a challenges for many patients living with these conditions.
Danial Arkwell, PhD
Advertisement
Articles by Danial Arkwell, PhD
Advertisement
Latest Updated Articles
How Efficient Cold Chain Logistics Can Change the Lives of Rare Disease PatientsPublished: April 10th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Hardis Supply Chain Expands into North America as Demand for Cloud and Automation Accelerates
2
Pharma Pulse: Industry Backlash, GSK’s $2.2B Immunology Bet, and the Future of Wearables
3
Pharma Pulse: Global AI Alignment, the TrumpRx Pivot, and Nano-Delivery GLP-1s
4
ten23 health and BD Team Up to Scale Wearable Injectors for High-Volume Subcutaneous Drug Delivery
5